Autonomous Navigating Telepresence Robot for Alleviating Loneliness and Engaging Nursing Home Residents with and without Dementia
自主导航远程呈现机器人可缓解孤独感并吸引患有或未患有痴呆症的疗养院居民
基本信息
- 批准号:10255485
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaBoredomBrainBusinessesCOVID-19CaregiversCaringCessation of lifeChargeChronic DiseaseCollaborationsCommunicationConfusionConsentControl GroupsCoronary heart diseaseDataDementiaDeteriorationDiagnosisDisinfectionElderlyExerciseFamilyFamily memberFeasibility StudiesFundingGoalsGrantHealthHealth Insurance Portability and Accountability ActHomeHomes for the AgedImpaired cognitionIndustryInternetInterventionIntervention StudiesLinkLocationLonelinessLong-Term CareMeasuresMental DepressionMindModelingMoodsMusicNursing HomesOlder PopulationOnline SystemsPhasePilot ProjectsPopulationPreparationProceduresProtocols documentationQuality of lifeResearch PersonnelRiskRobotScheduleScheduling and StaffingSecureSmall Business Innovation Research GrantSocial isolationSocializationStrokeSystemTabletsTechnologyTest ResultTestingTimeTrainingTravelVideoconferencingVisitWorkbasecognitive functioncommercializationdashboarddepressive symptomsfeasibility testinggroup interventionimprovedinfection riskintervention participantsloved onesmeetingsphase II trialpreferenceprimary outcomesatisfactionsocial engagementsuccesstelepresenceusabilityvirtualvirtual visitweb site
项目摘要
1R43AG073001-01
Malinksy, Yuval
ABSTRACT
Social isolation has been an emerging critical challenge in the care of older adults in nursing homes where residents engage for an average of just 12 minutes per day with an activity director, a situation further exacerbated by Covid-19. Social isolation has detrimental effects on health as evidenced by the fact that 48.7% of nursing home residents have an active depression diagnosis. Loneliness is associated with increased depressive symptoms, risk for coronary heart disease and stroke, and is a key predictor of depression, health deterioration, and death in older adults. Greater loneliness is associated with lower cognitive function. Prior to COVID-19, 50.4% of nursing home residents were diagnosed with Alzheimer’s disease or Alzheimer’s disease related dementias. Socialization has been shown to reduce chronic disease, depression, slow down cognitive decline, and to improve quality of life in older adults. At the same time that the older population is growing rapidly in the U.S., there is a growing shortage in caregivers and staff in nursing homes and the staff are overworked.
Recent attempts to address the loneliness problem by providing tablets to nursing homes through the Care Act have caused the already understaffed nursing homes’ extra work since residents cannot figure out how to use the tablets on their own. Scheduling staff for setting up the tablets and facilitating communication for the residents at their rooms when families want to virtually meet, present another challenge.
The proposed project aims to integrate an affordable autonomous navigating telepresence robot with proven web-based scheduling and communications (Zoom) systems and a proven activities platform for seniors. The Vigorous Mind (“VM”) activities platform has been used successfully in dozens of senior living facilities and nursing homes for more than nine years. We will test the feasibility of implementing the integrated system at two nursing homes to address both social isolation and engagement as well as eliminating the need for staff to handle scheduling and to be present with residents with Alzheimer’s disease and other dementias or without in performing the virtual visits. The system will allow families to schedule virtual visits through the nursing homes’ website and the robot will autonomously navigate its way to the resident’s room at the scheduled time. The family member will be seen by the resident on the robot screen and the robot will move into the room where the resident and the family member will socialize and engage in VM activities. At the end of the virtual visit the robot will autonomously navigate its way to the disinfection station, be disinfected and charge its battery. The feasibility test will last three months and we shall collect data about user satisfaction with the sessions, with the technology and resident engagement. We will collect preliminary data on the success of the system in alleviating loneliness and improving mood among older adult residents of a nursing home in preparation for a larger and longer PHASE II SBIR.
If successful, this technology could be an affordable solution for addressing loneliness and social isolation in long-term care and senior living facilities and in homes of older adults who live with caregivers, and at the same time save caregivers time and give them some respite.
1R43AG073001-01
尤瓦尔·马林斯基
抽象的
社会隔离已成为疗养院老年人护理中面临的一个新的严峻挑战,疗养院的居民平均每天与活动主管接触的时间只有 12 分钟,而 Covid-19 进一步加剧了这种情况,社会隔离对健康产生了不利影响。 48.7% 的疗养院居民有积极的抑郁症诊断,孤独感与抑郁症状、冠心病和中风风险增加有关,并且是老年人抑郁、健康恶化和死亡的关键预测因素。 .更大在 COVID-19 之前,50.4% 的疗养院居民被诊断患有阿尔茨海默病或阿尔茨海默病相关的痴呆症,社交化已被证明可以减少慢性疾病、抑郁症、减缓认知能力下降并改善。老年人的生活质量在美国老年人口迅速增长的同时,疗养院的护理人员和工作人员日益短缺,而且工作人员过度劳累。
最近通过《护理法案》向疗养院提供平板电脑来解决孤独问题的尝试,给本已人手不足的疗养院带来了额外的工作,因为居民不知道如何自行使用平板电脑来安排工作人员设置平板电脑和提供便利。当家人想要虚拟见面时,居民在房间里的沟通是另一个挑战。
拟议项目旨在将经济实惠的自主导航远程呈现机器人与经过验证的基于网络的调度和通信(Zoom)系统以及经过验证的老年人活动平台“Vigorous Mind”(“VM”)活动平台已在数十名老年人中成功使用。我们将测试在两个疗养院实施集成系统的可行性,以解决社会隔离和参与问题,并消除工作人员处理日程安排和与居民在一起的需要。阿尔茨海默病和其他疾病该系统将允许家庭通过疗养院的网站安排虚拟访问,机器人将在预定时间自动导航到居民的房间。在机器人屏幕上,机器人将进入居民和家庭成员进行社交和参与虚拟活动的房间。虚拟访问结束时,机器人将自动导航到消毒站,进行消毒和充电。其电池的可行性测试将持续三年。我们将收集有关用户对会议、技术和居民参与度的满意度的数据。我们将收集有关该系统在缓解疗养院老年居民的孤独感和改善情绪方面是否成功的初步数据,为更大规模的会议做好准备。和更长的第二阶段 SBIR。
如果成功,这项技术可能成为一种经济实惠的解决方案,用于解决长期护理和老年生活设施以及与护理人员住在一起的老年人家中的孤独和社会孤立问题,同时节省护理人员的时间并让他们得到一些喘息的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuval Malinsky其他文献
Yuval Malinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuval Malinsky', 18)}}的其他基金
Autonomous Navigating Robot for Detecting Falls and Risk of Falls in Nursing Home Residents with Alzheimer's Disease /ADRD
用于检测患有阿尔茨海默病/ADRD 的疗养院居民跌倒和跌倒风险的自主导航机器人
- 批准号:
10698704 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Autonomous Navigating Robot for Detecting Falls and Risk of Falls in Nursing Home Residents with Alzheimer's Disease /ADRD
用于检测患有阿尔茨海默病/ADRD 的疗养院居民跌倒和跌倒风险的自主导航机器人
- 批准号:
10698704 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Integrated Web-Based Customer Engagement, Physical Exercise, and Coaching Platform for Older Adults
面向老年人的集成的基于网络的客户参与、体育锻炼和辅导平台
- 批准号:
9408822 - 财政年份:2017
- 资助金额:
$ 50万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
基于miRNA介导ceRNA网络调控作用的防治阿尔茨海默病及认知障碍相关疾病药物的发现研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
LMTK1调控核内体转运介导阿尔茨海默病神经元Reserve机制研究
- 批准号:81903703
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
MBP酶切L1CAM介导的线粒体自噬在阿尔茨海默病中的作用和机制
- 批准号:81901296
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
基于自组装多肽纳米探针检测蛋白标志物用于阿尔茨海默病精准诊断的研究
- 批准号:31900984
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Investigate the utility of APLP1 as an endosomal biomarker for Alzheimer's Disease in Down Syndrome
研究 APLP1 作为唐氏综合症阿尔茨海默氏病内体生物标志物的效用
- 批准号:
10727134 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别: